Javitt Daniel C. 4
4 · NRX Pharmaceuticals, Inc. · Filed Jun 7, 2022
Insider Transaction Report
Form 4
Javitt Daniel C.
10% Owner
Transactions
- Sale
Common Stock
2022-06-03$0.70/sh−243,596$171,102→ 12,859,080 total(indirect: By LLC) - Sale
Common Stock
2022-06-06$0.67/sh−115,657$76,947→ 12,743,423 total(indirect: By LLC) - Sale
Common Stock
2022-06-07$0.65/sh−86,459$55,861→ 12,656,964 total(indirect: By LLC)
Footnotes (1)
- [F1]Held by Glytech LLC of which the Reporting Person is the sole owner.